GSK Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK Pharma Quarterly Results    (GLXO)

Here are the latest quarterly results of GSK Pharma. For more details, see the GSK Pharma financial fact sheet and GSK Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

GSK Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-18
3
Sep-18
3
Dec-18
3
Mar-19
3
Jun-19
3
Sep-19
3
Dec-19
3
Mar-20
8-Qtr Chart
Click to enlarge
Net Sales Rs m7,3578,1638,2547,5127,8808,8217,7877,759 
Other income Rs m178148164525305156163152 
Turnover Rs m7,5348,3118,4188,0378,1868,9777,9497,910 
Expenses Rs m5,9536,5126,8805,8766,2256,8796,5406,018 
Gross profit Rs m1,3211,5341,6551,6051,6555,954-6,1231,854 
Depreciation Rs m114115120137191227183226 
Interest Rs m2211993015 
Profit before tax Rs m1,3831,5651,6981,9921,7605,874-6,1731,764 
Tax Rs m497557568761626846268385 
Profit after tax Rs m8861,0081,1301,2301,1355,028-6,4411,379 
Gross profit margin %18.018.820.021.421.067.5-78.623.9 
Effective tax rate %35.935.633.538.235.514.4-4.321.8 
Net profit margin %12.012.313.716.414.457.0-82.717.8 
Diluted EPS Rs 5.2 5.9 6.7 7.3 6.7 29.7 -38.0 8.1  
Diluted EPS (TTM) Rs 24.4 22.7 24.1 25.1 26.6 50.3 5.6 6.5  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: GSK Pharma 2QFY20 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   NATCO PHARMA  INDRAPRASTHA MEDICAL  DISHMAN PHARMA  PIRAMAL ENTERPRISES  INDOCO REMEDIES  

Compare GSK PHARMA With:   NATCO PHARMA  INDRAPRASTHA MEDICAL  DISHMAN PHARMA  PIRAMAL ENTERPRISES  INDOCO REMEDIES  

Compare GSK PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Flat; Telecom and Healthcare Stocks Witness Selling(Closing)

Indian share markets erased the opening gains and ended marginally lower for the second consecutive day today.

Views on news

GSK PHARMA Share Price Up by 5%; BSE HEALTHCARE Index Down 0.6% (Market Updates)

Aug 13, 2020 | Updated on Aug 13, 2020

GSK PHARMA share price is trading up by 5% and its current market price is Rs 1,540. The BSE HEALTHCARE is down by 0.6%. The top gainers in the BSE HEALTHCARE Index are GSK PHARMA (up 5.2%) and CAPLIN POINT (up 8.2%). The top losers are GRANULES INDIA and ASTRAZENECA PHARMA (down 0.1%).

GSK PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 398.9% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, GSK PHARMA has posted a net profit of Rs 5 bn (up 398.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 28.1% (Quarterly Result Update)

Jul 24, 2019 | Updated on Jul 24, 2019

For the quarter ended June 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 28.1% YoY). Sales on the other hand came in at Rs 8 bn (up 7.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

More Views on News

Most Popular

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

Is It Time to Book Profits in Gold and Silver? (Fast Profits Daily)

Aug 10, 2020

Gold and silver have delivered phenomenal returns this year. Is it time to take some money of the table?

Forget the Nifty and Sensex for the Next 1 or 2 Years and Focus on These Stocks (Profit Hunter)

Aug 6, 2020

Stocks from the essential small cap space are likely to be outperformers over the next 1 or 2 years.

This 20 Year Cycle Suggests Gold is Set for an August Rally (Profit Hunter)

Jul 31, 2020

The real reason why gold prices will go up more.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Aug 13, 2020 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GSK PHARMA

COMPARE GSK PHARMA WITH

MARKET STATS